AHSG and Obesity: found that, when fed a HFD, fetuin-A knockout mice did not experience significant weight gain and remained insulin sensitive; This suggests that fetuin-A may play an important role in glycolipid metabolism and may be a new therapeutic target for the treatment of type 2 diabetes, obesity, and other insulin-resistant diseases (87).